News related to Hepsera (Adefovir Dipivoxil) and/or conditions it is approved for
Liver cancer in chronic hepatitis B patients can be prevented by antiviral therapy
Source: Liver Disease / Hepatitis News From Medical News Today [2014.06.25]
One of the most severe complications of hepatitis B is the development of liver cancer, which is responsible for approximately 745,000 deaths worldwide each year.
Entecavir Does Not Eliminate HCC Risk in Hepatitis B Patients
Source: Medscape Gastroenterology Headlines [2014.07.21]
Patients taking entecavir for chronic hepatitis B are still at risk for hepatocellular carcinoma (HCC), a recent study suggests.
Reuters Health Information